June’s jobs report is a one-off following several months of very strong jobs days, and it doesn’t reflect the state of the underlying economy. Only 57,000 jobs were created last month, while the unemployment rate fell to 4.2%, and the labor force participation rate fell to 61.5%. The job creation in previous months was also revised downward….
The vast majority of Americans back banning social media for children under the age of 16, according to a Pew Research Center poll released Wednesday. Almost 6 in 10 U.S. adults support a social media ban for children under 16 years old, the survey suggests. Meanwhile, roughly one-in-five respondents oppose such a ban and about…
The Trump administration’s systematic dismantling of Joe Biden’s offshore wind dreams continued on Monday. The Department of Interior (DOI) announced an agreement with Duke Energy in which the company agrees to cancel its plans for a huge wind project offshore North Carolina — adjacent to the Carolina Long Bay area — in exchange for a…
The Department of Justice’s Civil Rights Division sued Virginia Wednesday, claiming a ban on modern semiautomatic firearms violated the Second Amendment. Since Thursday, state judges in Virginia’s Lancaster County and Washington County issued preliminary injunctions preventing enforcement of a ban on modern semiautomatic firearms that Democratic Virginia Gov. Abigail Spanberger signed into law on May 14. In…
A prominent agriculture lobbyist warned President Donald Trump that that taking action to promote pesticide alternatives would cause him to lose support among farming interests, Axios first reported Wednesday. The purported confrontation suggests that supporters of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) movement who hope to…
Anthropic announced Tuesday that it is launching new pre-clinical drug discovery programs in an attempt to produce artificial intelligence-powered tools for drugmakers. Anthropic Head of Life Sciences Eric Kauderer-Abrams said during an “AI for Science” event in San Francisco that the AI company plans to prioritize discovering drugs to treat “neglected” diseases “outside the scope”…
